Luc Valiquette1,
Francesco Montorsi2,
Wayne J. G. Hellstrom3,
Francois Giuliano4,
Martin Homering5,
Terry Taylor6,
Ian Eardley7
Canadian Journal of Urology, Vol.12, No.3, pp. 2687-2698, 2005
Abstract Objective: To assess success rates in ability to penetrate (Sexual Encounter Profile question 2 [SEP2]) and maintain erections to completion of intercourse (SEP3) from time of dosing to start of sexual activity in a retrospective analysis of two pivotal trials.
Methods: In two randomized, double-blind studies, men with ED for >6 months received vardenafil 5 mg, 10 mg, or 20 mg or placebo for 12-26 weeks. Patients were instructed to start sexual activity 1 hour after dosing. In this retrospective pooled analysis, patient diary questions through week 12 were analyzed, providing attempt data was recorded 0-12 hours… More >